Safety and efficacy of azacitidine in myelodysplastic syndromes

PURPOSE: The clinical efficacy, different dosages, treatment schedules, and safety of azacitidine are reviewed. SUMMARY: Azacitidine is the first drug FDA-approved for the treatment of myelodysplastic syndromes that has demonstrated improvements in overall survival and delaying time to progression t...

Full description

Saved in:
Bibliographic Details
Main Authors: Vigil, Carlos E, Martin-Santos, Taida, Garcia-Manero, Guillermo
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2010
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948932/
https://ncbi.nlm.nih.gov/pubmed/20957213
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items